Wolfe Research Begins Coverage on Roivant Sciences (NASDAQ:ROIV)

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

Related Keywords

United States ,America ,Piper Sandler ,Vivek Ramaswamy ,Eric Venker ,Roivant Sciences ,Jpmorgan Chase Co ,Deutsche Bank Aktiengesellschaft ,News Ratings For Roivant Sciences Daily ,Roivant Sciences Ltd ,Blackrock Inc ,Wolfe Research ,Insider Activity At Roivant Sciences ,Roivant Sciences Stock Performance ,Morgan Stanley ,Analyst Recommendations For Roivant Sciences ,Securities Exchange Commission ,Institutional Investors Weigh In On Roivant Sciences ,Free Report ,Bank Aktiengesellschaft ,Moderate Buy ,Exchange Commission ,Capital Management ,Square Capital ,Get Free Report ,Sciences Ltd ,Roivant Sciences Daily ,Nasdaq Roiv ,Roiv ,Medical ,Initiated Coverage ,